Skip to main content

Advertisement

SpringerLink
Log in

Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship

  • Current Management of Fungal Infections (RE Lewis, Section Editor)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Background

Invasive candidiasis (IC) including candidemia and deep-seated candidiasis is associated with up to 50 % overall mortality and up to $80,000 in attributable cost (2015 US$). Rapid diagnostic tests (RDTs) for Candida have been developed. However, whether RDTs along with real-time decision support translate to better attainment of stewardship goals—improve clinical outcomes, minimize unintended consequences of antifungal use, and reduce healthcare costs—is unknown. The purpose of this systematic review was to provide an up-to-date review of recently published studies that have assessed how RDTs for IC impact attainment of these goals.

Methods

Three electronic bibliographic databases were searched using a pre-defined search strategy evaluating the impact of RDTs for IC on attainment of antifungal stewardship goals. Quality assessments were performed by two reviewers using established study methodology metrics.

Results and Conclusions

Eight studies were identified of which five had sufficient information to be included in the review. Despite the limitations of the various studies and the different methodologies employed, the studies all produced similar conclusions. Compared to conventional methods and baseline stewardship activities, the integration of RDTs for IC and real-time decision support, mainly through antifungal stewardship, was associated with decreased mortality, more optimal use of antifungals, and reduced healthcare costs. However, larger clinical studies are needed to confirm these trends.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. The New England Journal of Medicine. 2014;370(13):1198–208. doi:10.1056/NEJMoa1306801.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2004;39(3):309–17. doi:10.1086/421946.

    Article  Google Scholar 

  3. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(8):1110–22. doi:10.1093/cid/cis021.

    Article  CAS  Google Scholar 

  4. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2005;41(9):1232–9. doi:10.1086/496922.

    Article  Google Scholar 

  5. Clancy CJ, Nguyen MH. Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of America. 2013;56(9):1284–92. doi:10.1093/cid/cit006.

    Article  Google Scholar 

  6. Cobos-Trigueros N, Kaasch AJ, Soriano A, Torres JL, Vergara A, Morata L, et al. Time to positivity and detection of growth in anaerobic blood culture vials predict the presence of Candida glabrata in candidemia: a two-center European cohort study. Journal of Clinical Microbiology. 2014;52(8):3082–4. doi:10.1128/JCM.01198-14.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Huang L, Zhang YY, Sun LY. Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2013;32(7):917–22. doi:10.1007/s10096-013-1826-8.

    Article  CAS  Google Scholar 

  8. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrobial Agents and Chemotherapy. 2005;49(9):3640–5. doi:10.1128/aac.49.9.3640-3645.2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, et al. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. The Journal of antimicrobial chemotherapy. 2011;66(9):2146–51. doi:10.1093/jac/dkr244.

    Article  CAS  PubMed  Google Scholar 

  10. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006;43(1):25–31. doi:10.1086/504810.

    Article  CAS  Google Scholar 

  11. Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. International journal of antimicrobial agents. 2007;29(5):557–62. doi:10.1016/j.ijantimicag.2007.01.001.

    Article  CAS  PubMed  Google Scholar 

  12. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, et al. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance(R)) registry, 2004-2008. Diagnostic microbiology and infectious disease. 2012;74(4):323–31. doi:10.1016/j.diagmicrobio.2012.10.003.

    Article  PubMed  Google Scholar 

  13. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009). International journal of antimicrobial agents. 2011;38(1):65–9. doi:10.1016/j.ijantimicag.2011.02.016.

    Article  CAS  PubMed  Google Scholar 

  14. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;56(12):1724–32. doi:10.1093/cid/cit136.

    Article  Google Scholar 

  15. Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2014;59(6):819–25. doi:10.1093/cid/ciu407.

    Article  CAS  Google Scholar 

  16. Pfaller MA, Castanheira M. Nosocomial candidiasis: antifungal stewardship and the importance of rapid diagnosis. Medical mycology. 2016;54(1):1–22. doi:10.1093/mmy/myv076.

    PubMed  Google Scholar 

  17. Fortun J, Meije Y, Buitrago MJ, Gago S, Bernal-Martinez L, Peman J, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. The Journal of antimicrobial chemotherapy. 2014;69(11):3134–41. doi:10.1093/jac/dku225.

    Article  CAS  PubMed  Google Scholar 

  18. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;60(6):892–9. doi:10.1093/cid/ciu959.

    Article  Google Scholar 

  19. Heil EL, Daniels LM, Long DM, Rodino KG, Weber DJ, Miller MB. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2012;69(21):1910–4. doi:10.2146/ajhp110604.

    Article  CAS  Google Scholar 

  20. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2013;57(9):1237–45. doi:10.1093/cid/cit498. This pre-post quasi-experimental study implemented MALDI-TOF and real-time antifungal stewardship in patients with candidemia and demonstrated a trend for faster time to active therapy and a lower mortality rate compared to conventional methods and baseline stewardship activities.

    Article  CAS  Google Scholar 

  21. Banerjee R, Teng CB, Cunningham SA, Ihde SM, Steckelberg JM, Moriarty JP, et al. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015;61(7):1071–80. doi:10.1093/cid/civ447. This open-label randomized controlled trial suggested that electronic templated comments can be used to communicate results of a rapid diagnostic test and deliver straightforward recommendations to clinicians, such as discontinuing treatment of contaminants and escalating therapy in patients with positive blood cultures. This was the first study to show that real-time antifungal stewardship is not the only effective form of support that can aid clinicians in acting on the results of a rapid diagnostic test.

    Article  Google Scholar 

  22. Holtzman C, Whitney D, Barlam T, Miller NS. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. Journal of clinical microbiology. 2011;49(4):1581–2. doi:10.1128/jcm.02461-10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Carver PL, Lin SW, DePestel DD, Newton DW. Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. Journal of clinical microbiology. 2008;46(7):2381–3. doi:10.1128/jcm.00801-08.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. Journal of clinical microbiology. 2012;50(1):127–33. doi:10.1128/jcm.06169-11.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Dellit TH, Owens RC, McGowan Jr JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007;44(2):159–77. doi:10.1086/510393.

    Article  Google Scholar 

  26. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:10.1007/s10654-010-9491-z.

    Article  PubMed  Google Scholar 

  27. Ofman JJ, Sullivan SD, Neumann PJ, Chiou CF, Henning JM, Wade SW, et al. Examining the value and quality of health economic analyses: implications of utilizing the QHES. Journal of managed care pharmacy : JMCP. 2003;9(1):53–61.

    Article  PubMed  Google Scholar 

  28. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. Jama. 2001;285(15):1992–5.

    Article  CAS  PubMed  Google Scholar 

  29. Harris DM, Hata DJ. Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Annals of clinical microbiology and antimicrobials. 2013;12:2. doi:10.1186/1476-0711-12-2.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Stone NR, Gorton RL, Barker K, Ramnarain P, Kibbler CC. Evaluation of PNA-FISH yeast traffic light for rapid identification of yeast directly from positive blood cultures and assessment of clinical impact. Journal of clinical microbiology. 2013;51(4):1301–2. doi:10.1128/JCM.00028-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Whittier S, Della-Latta P. Clinical relevance of rapid identification of candidemia using a dual color PNA FISH assay. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2014;21S:212.

    Article  Google Scholar 

  32. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, et al. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. The Annals of pharmacotherapy. 2014;48(6):683–90. doi:10.1177/1060028014529928. ̇This 5000-person Monte Carlo simulation study demonstrated that utilizing T2Candida in patients at high risk for candidemia and receiving empiric echinocandins can result in faster time to discontinuing unnecessary antifungal therapy and substantial cost savings.

    Article  PubMed  Google Scholar 

  33. Bilir SP, Ferrufino CP, Pfaller MA, Munakata J. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future microbiology. 2015;10(7):1133–44. doi:10.2217/fmb.15.29. ̈This 1-year decision-tree model conducted from a hospital’s perspective demonstrated that utilizing T2Candida in patients at high-risk for candidemia can reduce morality rate and generate substantial total cost savings.

    Article  CAS  PubMed  Google Scholar 

  34. Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2005;41(1):77–82. doi:10.1086/430713.

    Article  Google Scholar 

  35. Goodacre S. Uncontrolled before-after studies: discouraged by Cochrane and the EMJ. Emergency medicine journal : EMJ. 2015;32(7):507–8. doi:10.1136/emermed-2015-204761.

    Article  PubMed  Google Scholar 

  36. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled clinical trials. 1996;17(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  37. Forrest GN, Mankes K, Jabra-Rizk MA, Weekes E, Johnson JK, Lincalis DP, et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. Journal of clinical microbiology. 2006;44(9):3381–3. doi:10.1128/jcm.00751-06.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Archives of pathology & laboratory medicine. 2013;137(9):1247–54. doi:10.5858/arpa.2012-0651-OA.

    Article  Google Scholar 

  39. Pogue JM, Mynatt RP, Marchaim D, Zhao JJ, Barr VO, Moshos J, et al. Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremia. Infection control and hospital epidemiology. 2014;35(2):132–8. doi:10.1086/674849.

    Article  PubMed  Google Scholar 

  40. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Peterson LE, et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. The Journal of infection. 2014;69(3):216–25. doi:10.1016/j.jinf.2014.05.005.

    Article  PubMed  Google Scholar 

  41. Box MJ, Sullivan EL, Ortwine KN, Parmenter MA, Quigley MM, Aguilar-Higgins LM, et al. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy. 2015;35(3):269–76. doi:10.1002/phar.1557.

    Article  PubMed  Google Scholar 

  42. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010;51(9):1074–80. doi:10.1086/656623.

    Article  Google Scholar 

  43. Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, et al. Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy. 2013;33(2):137–43. doi:10.1002/phar.1186.

    Article  PubMed  Google Scholar 

  44. Reed EE, West JE, Keating EA, Pancholi P, Balada-Llasat JM, Mangino JE, et al. Improving the management of candidemia through antimicrobial stewardship interventions. Diagnostic microbiology and infectious disease. 2014;78(2):157–61. doi:10.1016/j.diagmicrobio.2013.11.012.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Houston College of Pharmacy, 1441 Moursund St, Houston, TX, 77030, USA

    Amelia K. Sofjan, Rachel J. Musgrove & Kevin W. Garey

Authors
  1. Amelia K. Sofjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachel J. Musgrove
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin W. Garey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kevin W. Garey.

Ethics declarations

Conflict of Interest

Amelia K. Sofjan and Rachel J. Musgrove declare that they have no conflict of interest. Kevin W. Garey reports grants from T2 Biosystems outside submitted work.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Current Management of Fungal Infections

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sofjan, A.K., Musgrove, R.J. & Garey, K.W. Impact of New Diagnostic Approaches for Invasive Candidiasis on Antifungal Stewardship. Curr Fungal Infect Rep 10, 68–77 (2016). https://doi.org/10.1007/s12281-016-0257-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-016-0257-2

Keywords

Search

Navigation